Pirfenidone Prevents Capsular Contracture After Mammary Implantation
- 30 October 2007
- journal article
- research article
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 32 (1) , 32-40
Abstract
Background Pirfenidone (PFD), a new antifibrotic and antiinflammatory agent, prevents and resolves fibrous tissue. This study evaluated the effect of PFD on adverse events in mammary implants using an animal model. Mammary implantation, the most frequent aesthetic surgery, may present several complications after surgery such as swelling, capsule contracture, hardness, and pain. Methods Wistar rats underwent submammary implantation with either smooth or textured silicone gel implants and were administrated 200 mg/kg of PFD daily. The control group received saline. The animals were killed at 8 weeks. The capsular tissue of both implants was removed for histologic and molecular analyses. Results Typical postaugmentation periimplant capsules with opacity on adjacent tissues developed 8 weeks after silicone implantation. No significant differences were observed between the textured and smooth implants in any analyzed parameter. Clearly, PFD reduced capsule thickness around submmamary tissue, fibroblast-like cell proliferation, and recruitment of inflammatory cells. The total cell numbers per field were reduced as well. In contrast, the control group presented abundant mononuclear cell infiltration and fibroblast-like cell proliferation. The total content of collagen in the PFD group was 50% less than in the control group. Fibroblast cells displayed 45% less activated phenotype in the PFD group than in the control group, as determined by immunohistochemistry techniques. In the PFD animals, transforming growth factor-β (TGF-β) decreased 85% and collagen 1 gene expression 60%, compared with the control group. Conclusion The findings show a positive effect of PFD on mammary contracture in 10 rats. Despite the small number of animals, the differences found in 10 control rats encourage the authors to propose a larger study later and to suggest PFD as a potential preventive strategy in human mammary implantation surgery.Keywords
This publication has 34 references indexed in Scilit:
- A pilot study in patients with established advanced liver fibrosis using pirfenidoneGut, 2006
- Pirfenidone effectively reverses experimental liver fibrosisJournal of Hepatology, 2002
- Influence of local complications on capsule formation around model implants in a rat modelJournal of Biomedical Materials Research Part A, 2002
- Ten-Year Review of a Prospective Randomized Controlled Trial of Textured versus Smooth Subglandular Silicone Gel Breast ImplantsPlastic and Reconstructive Surgery, 2000
- Periprosthetic Breast Capsules Contain the Fibrogenic Cytokines TGF-β1 and TGF-β2, Suggesting Possible New Treatment ApproachesAnnals of Plastic Surgery, 2000
- The Effects of Intraprosthetic Methylprednisolone on Implant Capsules and Surrounding Soft TissueAnnals of Plastic Surgery, 1984
- Rate of Diffusion of Solu-Medrol across the Silastic Membranes of Breast Prostheses—An In Vitro StudyAnnals of Plastic Surgery, 1982
- Elevated Glycosaminoglycans and Chondroitin 4-Sulfate, and Other Properties of Contracted Human Prosthesis CapsulesAnnals of Plastic Surgery, 1981
- Capsular Contracture and Steroid-Related Complications After Augmentation Mammaplasty A Preliminary StudyPlastic and Reconstructive Surgery, 1979
- THE ROLE OF STEROIDS IN PREVENTION OF CIRCUMFERENTIAL CAPSULAR SCARRING IN AUGMENTATION MAMMAPLASTYPlastic and Reconstructive Surgery, 1974